Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Products>This Product
  Products


Primate ES Cell Medium: for human ES/iPSC Culture

Product Description
ReproCELL’s Primate ES Cell Medium is a serum-free formulation that was jointly developed by ReproCELL and Kyoto University. This media enabled development of the world’s first human iPS cells in 2007 by Prof Shinya Yamanaka and his colleagues#. Following this breakthrough, ReproCELL’s Primate ES Cell Culture Medium has been successfully adopted for culture of ES and iPS cells by numerous labs throughout the world. This media has been specifically developed to simplify the process of ES and iPS cell development for human and other primate cells. You just need to add bFGF prior to use* and the medium is ready for use.

Each lot is functionally tested by using human iPS cells.
Lot-to-lot control of other critical criteria including osmolarity, pH, sterility and mycoplasma.
Just add bFGF before use*. No other mixing required.
Serum-free
Product Primate ES Cell Medium: for human ES/iPSC Culture
Company ReproCell Products
Price Request a quote
More Information View company product page
Catalog Number RCHEMD001
Quantity 500 mL
Company Logo

ReproCell Products
Reprocell Inc KDX Shin-yokohama 381 Bldg 8F 3-8-11, Shin-yokohama, Kohoku-ku, Yokohama Kanagawa 222-0033, Japan

Tel: +81 45-475-3887
Fax: +81 45-474-1006
Email: info_repro@reprocell.com



Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!